Clinical course of patient no.

Clinical course of patient no.

<p><b>1.</b> (A) Patient 1 underwent letrozole treatment and showed a possible suppressive effect of letrozole on liver fibrosis. (B) Ultrasonograms at baseline and 48 months of letrozole treatment.</p>

Saved in:

Bibliographic Details
Main Author:	Kazuyoshi Ohkawa (836847) (author)
Other Authors:	Tasuku Nakabori (12174456) (author), Kaori Mukai (836844) (author), Kazuhiro Kozumi (19942495) (author), Makiko Urabe (12174453) (author), Yugo Kai (8980970) (author), Ryoji Takada (4860376) (author), Kenji Ikezawa (12174432) (author), Yuko Yamaguchi (55359) (author), Takuya Nagao (19942498) (author), Hatsune Enomoto (19942501) (author), Hidehisa Tachiki (11606437) (author), Ayako Higuchi (19942504) (author), Noriyuki Watanabe (434683) (author), Takahiro Nakayama (4567198) (author)
Published:	2024
Subjects:	Medicine Cell Biology Pharmacology Biotechnology Cancer Science Policy Hematology Infectious Diseases Virology Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified platelet ratio index mean aspartate aminotransferase possible suppressive effect suppress liver fibrosis preventing liver fibrosis 4 index tended treated patient groups div >< p 24 months compared 23 consecutive patients underwent anastrozole treatment liver fibrosis 4 index 24 months treated patients patient characteristics suppressive impact suppressive effects treatment strategies anastrozole treatment ≥ 2 unpaired student three patients significantly lower significant reduction significant decrease pharmacological effects paired student murine models mean fib limited number fisher exact findings support clinical validation clinical setting breast cancer better understand 026 ). 023 ), 013 ).
Tags:	Add Tag No Tags, Be the first to tag this record!

Cannot write session to /tmp/vufind_sessions/sess_ha3532l2c1ha552of1adoj407g